BIOLOGIC/DISEASE-MODIFYING ANTIRHEUMATIC DRUG (DMARD)
Cosentyx is a prescription medication approved by the Food and Drug Administration (FDA) to treat ankylosing spondylitis, moderate to severe psoriatic arthritis, and plaque psoriasis. Cosentyx is also known by its drug name, Secukinumab.
Cosentyx is an immunomodulator, or in other words, a drug that modulates the immune system. It is considered a biologic disease-modifying antirheumatic drug (DMARD). Cosentyx is a genetically engineered antibody, or protein used by the immune system to identify and neutralize substances. Cosentyx is believed to work by inhibiting interleukin (IL)-17A, a chemical messenger involved in autoimmune attacks.
How do I take it?
After initial loading doses, Cosentyx is administered every four weeks by subcutaneous injection.
Cosentyx is available as a pen or prefilled syringe.
The FDA-approved label for Cosentyx lists common side effects including cold symptoms, upper respiratory tract infections, and diarrhea.
Rare but serious side effects listed for Cosentyx include severe infections, inflammatory bowel disease, and hypersensitivity reactions.
For more details about this treatment, visit:
Cosentyx – Novartis